HealthStream (NASDAQ:HSTM – Get Free Report) announced its quarterly earnings results on Monday. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02, FiscalAI reports. The company had revenue of $83.31 million during the quarter, compared to the consensus estimate of $82.24 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%.
HealthStream Stock Performance
HSTM opened at $34.58 on Tuesday. The business’s 50-day simple moving average is $31.05 and its 200-day simple moving average is $25.65. HealthStream has a one year low of $19.50 and a one year high of $35.60. The stock has a market capitalization of $1.01 billion, a P/E ratio of 48.03, a price-to-earnings-growth ratio of 3.90 and a beta of 0.45.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on HSTM shares. Freedom Capital upgraded HealthStream to a “hold” rating in a report on Tuesday, October 13th. Wall Street Zen raised HealthStream from a “hold” rating to a “buy” rating in a report on Saturday. Canaccord Genuity Group increased their price target on shares of HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a research note on Tuesday, July 21st. Citigroup reiterated a “market perform” rating on shares of HealthStream in a research note on Tuesday, October 27th. Finally, Weiss Ratings upgraded shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. One equities research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $27.00.
Check Out Our Latest Stock Analysis on HSTM
Insider Activity
In related news, Director Linda Rebrovick sold 12,000 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $35.00, for a total value of $420,000.00. Following the completion of the sale, the director directly owned 39,329 shares of the company’s stock, valued at $1,376,515. This represents a 23.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Robert Frist, Jr. sold 144,068 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $29.50, for a total value of $4,250,006.00. Following the transaction, the chief executive officer owned 3,907,038 shares in the company, valued at $115,257,621. This represents a 3.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.40% of the stock is currently owned by insiders.
About HealthStream
HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.
The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.
Further Reading
- Five stocks we like better than HealthStream
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.
